A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, November 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 9 patents

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 23 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae family…

Grant US-9339523-B2

United States of America

Estrogenic extracts of Astragalus membranaceus fisch. bge. var. mongolicus bge. of the…

Grant US-9220740-B2

United States of America

Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof

Grant US-9155770-B2

United States of America

Methods of detecting and treatment of cancers using Scutellaria barbata extract

Grant US-8512961-B2

United States of America

Process of making purified extract of Scutellaria barbata D. Don

Grant US-8197868-B2

United States of America

Composition for treatment of menopause

Grant US-8110228-B2

United States of America

Estrogenic extracts of Ligustrum lucidum ait. of the oleaceae family and uses thereof

Grant US-8092841-B2

United States of America

Scutellaria barbata extract for the treatment of cancer

Grant US-7700136-B2

United States of America

SCUTELLARIA BARBATA EXTRACT AND COMBINATIONS FOR THE TREATMENT OF CANCER

Application WO-2009067555-A1

World Intellectual Property Organisation (WIPO)